Search

ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

SCImago Journal & Country Rank

2026, Vol 16, No. 1

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of integrative fields within Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Why Publish with APB?

Free of charge publication for all article types
Fast and constructive peer review
Simple and efficient online submission
Author-friendly review process
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Research Article

1. The Effect of Spironolactone on β-amyloid-Induced Memory Impairment in Male Rats: The Role of Microglial Inhibition

Mohammad Mehdipour , Masoumeh Emamghoreishi , Majid Reza Farrokhi , Elahe Amirinezhadfard , Mojtaba Keshavarz*

Adv Pharm Bull. 2022;12(3): 623-631. doi: 10.34172/apb.2022.065

PMCID: PMC9348523 PMID: 35935039 Scopus ID: 85140417719

Article

PDF

Full Text

XML

Cited By:

0

1

3

Original Article

2. The RNA-Binding Proteins Promote Resistance of Microglial Cells to Hypoxia

Mohammad Khosravi* , Zohreh Ghotbeddin, Sorour Chinipardaz

Adv Pharm Bull. 2026;16(1): 91-109. doi: 10.34172/apb.025.46054

Article

PDF

Suppl 1

XML

Cited By:

Original Article

3. Histone Deacetylase Inhibitor Combined with Rosiglitazone Improves Cognitive Function Via Microglial Polarization and Increased Mature/Pro-BDNF in Alzheimer’s Disease

Melina Rafiey , Rahim Nosrati, Arash Pourgholaminejad, Saba Ahangaran, Parvin Babaei*

Adv Pharm Bull. 2026;16(1): 157-165. doi: 10.34172/apb.025.46129

Article

PDF

XML

Cited By:

Review Article

4. Purinergic Receptor (P2X7R): A Promising Anti-Parkinson’s Drug Target

Saivarshini Magham , M. Lalith Kumar, Praveen Thaggikuppe Krishnamurthy* , Neenu Shaji, Aishwarya Reddy Ramakkamma

Adv Pharm Bull. 2024;14(4): 807-818. doi: 10.34172/apb.43206

PMCID: PMC11970502 PMID: 40190682

Article

PDF

Full Text

XML

Cited By: